Salvage immunotherapy with subcutaneous recombinant interleukin 2 (rIL-2) and alpha-interferon (A-IFN) for stage D3 prostate carcinoma failing second-line hormonal treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples